LG 30435, a new potential antiasthmatic agent.

Eur Respir J

Institute of Pharmacological Sciences, University of Milan, Italy.

Published: October 1989

LG 30435 is a new quarternary phenothiazine derivative with H1-antihistaminic and antimuscarinic properties. The ability of LG 30435 to prevent changes in respiratory mechanics, induced by different mediators and the immunological reaction, was monitored together with biological and radioimmunological determination of circulating thromboxane-A2 (TxA2) in anaesthetized guinea-pigs. LG 30435 dose-dependently reduces the bronchoconstriction and TxA2 generation caused by different stimuli such as histamine, acetylcholine, leukotriene C4 (LTC4) and PAF-acether. In addition i.v. and aerosol administration of LG 30435 causes a dose-dependent reduction of the increase in airway resistance and TxA2 generation induced by ovalbumin challenge in actively sensitized animals. LG 30435 infused at different concentrations through the isolated guinea-pig lungs inhibits the TxB2 generation caused by different anaphylactic mediators, but not by arachidonic acid. These data, which further substantiate the bronchodilator activity of LG 30435 against a variety of stimuli and demonstrate its protective properties on lung anaphylaxis, suggest that this compound has a potential therapeutic value in the treatment of asthma.

Download full-text PDF

Source

Publication Analysis

Top Keywords

txa2 generation
8
generation caused
8
0
7
30435 potential
4
potential antiasthmatic
4
antiasthmatic agent
4
agent 30435
4
30435 quarternary
4
quarternary phenothiazine
4
phenothiazine derivative
4

Similar Publications

This study aims to reveal the effect and mechanism of Dendrobii Officinalis Caulis water extract on the rat model of hyperviscosity induced by a high-sugar, high-salt, and high-fat diet. Thirty-six male SD rats were randomized into normal, model, Compound Danshen Tablets(0.5 g·kg~(-1)), and low-, medium-, and high-dose(0.

View Article and Find Full Text PDF

Human Disabled-2 regulates thromboxane A signaling for efficient hemostasis in thrombocytopenia.

Nat Commun

November 2024

Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, 333, Taiwan, Republic of China.

Article Synopsis
  • Understanding platelet protein functions improves diagnosis and treatment of platelet disorders.
  • Researchers used human Disabled-2 knock-in (hDAB2-KI) mice to study how hDab2 regulates platelet function and bleeding in cases of low platelet counts (thrombocytopenia).
  • Findings show that hDab2 enhances certain platelet responses, leading to reduced bleeding time and indicating its significant role in managing bleeding severity related to thrombocytopenia.
View Article and Find Full Text PDF

NADPH oxidase 1/4 dual inhibitor setanaxib suppresses platelet activation and thrombus formation.

Life Sci

November 2024

College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea. Electronic address:

Aims: The production of reactive oxygen species (ROS) by NADPH oxidase (NOX) is able to induce platelet activation, making NOX a promising target for antiplatelet therapy. In this study, we examined the effects of setanaxib, a dual NOX1/4 inhibitor, on human platelet function and ROS-related signaling pathways.

Materials And Methods: In collagen-stimulated human platelets, aggregometry, assessment of ROS and Ca, immunoblotting, ELISA, flow cytometry, platelet adhesion assay, and assessment of mouse arterial thrombosis were performed in this study.

View Article and Find Full Text PDF

Background: Platelets, a type of anucleated cell, play a crucial role in cardiovascular diseases (CVDs). Therefore, targeting platelet activation is essential for mitigating CVDs. Endogenous agonists, such as collagen, activate platelets by initiating signal transduction through specific platelet receptors, leading to platelet aggregation.

View Article and Find Full Text PDF
Article Synopsis
  • - Prostaglandin I, produced by COX in endothelial cells, can cause vasodilation in some blood vessels while paradoxically leading to endothelium-dependent constriction (EDC) in others, particularly in diseases like hypertension, though the effects of PGIS deficiency on EDC and related cardiovascular issues are not well understood.
  • - The study utilized various mouse models, including wild-type and genetically modified knockouts, to measure the impact of PGIS deficiency and assess vasomotor responses, indicating alterations in nitric oxide production and signaling.
  • - Results showed that PGIS deficiency worsened EDC and led to increases in blood pressure and cardiac issues over time, but additional removal of the thromboxane receptor improved vascular function and reduced
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!